REUTERS: Drug developer Neurotrope Inc's shares tumbled nearly 80per cent on Monday after the company said its experimental treatment for ...
REUTERS: Drug developer Neurotrope Inc's shares tumbled nearly 80per cent on Monday after the company said its experimental treatment for Alzheimer's disease did not meet the main goal of a mid-stage study.
This is the second time in just over two years that the treatment - Bryostatin-1 - failed to meet its targets, raising questions about the drug's future. The treatment, Bryostatin-1, did not show any significant difference in patients after 13 weeks compared with those on placebo, the company said on Monday.
Neurotrope said it intends to conduct a complete review of the data to determine next steps in the treatment's development. Alzheimer's disease, which affects parts of the brain that control thought, memory and language, is a progressive condition that could seriously disrupt a patient's ability to carry out daily activities.
Several drugmakers such as Eli Lilly, AstraZeneca Plc, Roche AG, Pfizer Inc, Merck and Co Inc and Johnson and Johnson have all previously failed in their attempts to develop treatments for the memory-robbing disease.Source: Reuters
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Slovakian biotech firm in tentative Alzheimer's drug hopeFRANKFURT: An Alzheimer's vaccine developed by a privately held Slovakian biotech firm showed early signs of efficacy in a mid-stage trial, in a ...
Read more »
Hour Glass co-founder Jannie Chan starts two-week jail term after failed appealSINGAPORE — The Hour Glass co-founder Jannie Chan, 74, began serving a two-week jail term for contempt of court on Monday (Sept 9), after an appellate court threw out her appeal.
Read more »
EU has failed to fulfil 2015 deal commitments: Iran's nuclear chiefDUBAI (REUTERS) - Iran's nuclear chief said on Sunday the European parties to the 2015 nuclear deal have failed to fulfil their commitments under the pact, a day after Teheran announced further breaches of limits on its nuclear activity set by the pact.. Read more at straitstimes.com.
Read more »
Amgen drug shrinks lung cancer tumors in half of patients: studyREUTERS: An experimental Amgen Inc drug that targets a specific genetic mutation reduced tumor size in around half of advanced lung cancer ...
Read more »
Boeing suspends testing of 777X aircraftBoeing Co on Saturday announced it had suspended testing of its new widebody 777X aircraft as media reports said a cargo door failed in a ground ...
Read more »